Molecular Therapy
Self-Citation Ratio

The ISSN of Molecular Therapy is 15250024, 15250016. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Molecular Therapy is a Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Molecular Therapy is published by Cell Press, which is located in the United States. The Publication History of Molecular Therapy covers 2000-ongoing.

Molecular Therapy is a peer-reviewed scientific journal. The scope of Molecular Therapy covers Drug Discovery (Q1), Genetics (Q1), Medicine (miscellaneous) (Q1), Molecular Biology (Q1), Molecular Medicine (Q1), Pharmacology (Q1).

It is impossible to get a true picture of impact using a single metric alone, so a basket of metrics is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Metrics including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the Molecular Therapy.